Boticinal
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Boticinal - overview
Location
Courbevoie, -, France
Primary Industry
Retail
About
Boticinal is an online pharmacy that offers a wide range of health and wellness products, including skincare, dietary supplements, and baby care items from renowned brands, catering to individual and family needs. Boticinal operates as an online pharmacy providing a diverse selection of health products. The company is headquartered in Courbevoie, France. Founded by François Rochet, who has extensive experience in the pharmaceutical sector, Boticinal received investment from G Square Capital in February 2016.
The company has successfully managed one deal since its inception. Boticinal operates as an online pharmacy, providing a comprehensive range of over 15,000 products across various categories, including skincare, hygiene, dietary supplements, and baby care. The company's core offerings encompass well-known brands such as La Roche-Posay, Bioderma, and Arkopharma. These products are designed to meet the everyday health and wellness needs of consumers, addressing skin conditions, nutritional gaps, and maternal and infant care.
Boticinal primarily serves individual consumers and families looking for specialized items for children and infants, particularly in France and other Eurozone countries. In the most recent fiscal year of 2022, Boticinal generated revenue amounting to USD 75. 17 mn, with an EBITDA of USD -2. 43 mn.
The firm generates revenue through direct-to-consumer sales, offering individual products and promotions via its website. The pricing strategy is competitive, designed to appeal to various consumer demographics while ensuring product quality. Boticinal also employs a loyalty program to incentivize repeat transactions and offers free shipping on orders above a specified amount. Boticinal is focused on expanding its product offerings and entering new markets.
Though specific details on upcoming products or their launch dates were not disclosed, the company plans to utilize the funds received from G Square Capital in February 2016 to support these initiatives. Growth strategies may include targeted expansions into additional Eurozone countries to widen its customer base and enhance accessibility to its health solutions.
Current Investors
G Square
Primary Industry
Retail
Sub Industries
Beauty & Hygiene, Drug Stores/Convenience Stores, Diagnostic, Medical & Imaging Laboratories
Website
https://www.boticinal.com/
Verticals
E-commerce
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
Boticinal - timeline of key events
Boticinal - financials
| Fiscal Year Ended | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 29,009,289 | 31,873,419 | 33,663,536 | - | 57,086,711 | - | - | - |
| % Revenue Growth (YoY) | - | 9.9% | 5.6% | - | - | - | - | - |
| EBITDA (USD) | 344,686 | 99,892 | (3,034,862) | - | (3,265,533) | - | - | - |
| Operating Income (USD) | 322,340 | 67,151 | (3,078,213) | - | (3,753,445) | - | - | - |
| Operating Margin | 1.1% | 0.2% | (9.1%) | - | (6.6%) | - | - | - |
| % EBITDA Margin | 1.2% | 0.3% | (9.0%) | - | (5.7%) | - | - | - |
| NET Income (USD) | 227,177 | (275,290) | (4,110,686) | - | (1,091,330) | - | - | - |
| % Net Margin | 0.8% | (0.9%) | (12.2%) | - | (1.9%) | - | - | - |
Boticinal - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | Completed | Boticinal | - |
Displaying 1 - 1 of 1
Boticinal - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.